Search Results
Matches for acronym pd
334
rows returned
Results are ranked by score and user rating. Use the quick vote buttons when a candidate clearly matches or clearly does not.
| Acronym | Full Name | Score | User Rating | Judge | Search |
|---|---|---|---|---|---|
| PD | Parkinson's disease | 1074 | 7 |
|
|
| PD | peritoneal dialysis | 315 | 2 |
|
|
| PD | potential difference | 289 | 0 |
|
|
| PD | panic disorder | 111 | 2 |
|
|
| PD | Parkinson disease | 76 | 1 |
|
|
| PD | postnatal day | 60 | 1 |
|
|
| PD | probing depth | 40 | 6 |
|
|
| PD | personality disorder | 29 | 5 |
|
|
| PD | pars distalis | 25 | 4 |
|
|
| PD | progressive disease | 23 | 5 |
|
|
| PD | prism diopters | 21 | 7 |
|
|
| PD | population doublings | 20 | 6 |
|
|
| PD | postnatal days | 18 | 7 |
|
|
| PD | personality disorders | 18 | 3 |
|
|
| PD | proton density | 17 | 4 |
|
|
| PD | pocket depth | 13 | 7 |
|
|
| PD | pyloric dilator | 13 | 0 |
|
|
| PD | power Doppler | 12 | -1 |
|
|
| PD | probing depths | 11 | 2 |
|
|
| PD | Pharmacokinetic (PK) and pharmacodynamic | 10 | 3 |
|
|
| PD | Pharmacokinetics (PK) and pharmacodynamics | 10 | 0 |
|
|
| PD | Pick's disease | 10 | -2 |
|
|
| PD | pyridostigmine | 8 | 12 |
|
|
| PD | power of discrimination | 8 | 9 |
|
|
| PD | pancreaticoduodenectomy | 8 | 7 |
|
|
| PD | prenatal diagnosis | 7 | 7 |
|
|
| PD | pharmacodynamics | 7 | 6 |
|
|
| PD | prism dioptres | 7 | 5 |
|
|
| PD | Peyronie's disease | 7 | 4 |
|
|
| PD | Parkinson's | 5 | 19 |
|
|
| PD | preferred direction | 5 | 12 |
|
|
| PD | potential | 5 | 6 |
|
|
| PD | pancreatic duct | 5 | 3 |
|
|
| PD | permeability | 5 | 1 |
|
|
| PD | Psychopathic Deviate | 5 | -1 |
|
|
| PD | pressure | 4 | 8 |
|
|
| PD | percutaneous drainage | 4 | 7 |
|
|
| PD | persistent diarrhoea | 4 | 6 |
|
|
| PD | periodontitis | 4 | 6 |
|
|
| PD | pharmacokinetic (PK)-pharmacodynamic | 4 | 6 |
|
|
| PD | potential difference across the cell membrane | 4 | 6 |
|
|
| PD | Parkinson s disease | 4 | 6 |
|
|
| PD | protein deprived | 4 | 5 |
|
|
| PD | pupil diameter | 4 | 4 |
|
|
| PD | palladium | 4 | 3 |
|
|
| PD | performance decrement | 4 | 2 |
|
|
| PD | Paget's disease | 4 | 0 |
|
|
| PD | proton-density | 4 | 0 |
|
|
| PD | Parkinson's diseases | 4 | -1 |
|
|
| PD | pseudodeficiency | 3 | 5 |
|
|
| PD | preterm delivery | 3 | 4 |
|
|
| PD | pancreatoduodenectomy | 3 | 3 |
|
|
| PD | pyrimidine dimers | 3 | 3 |
|
|
| PD | primary dysmenorrhea | 3 | 3 |
|
|
| PD | population density | 3 | 3 |
|
|
| PD | Postural Drainage | 3 | 1 |
|
|
| PD | potential differences | 3 | 1 |
|
|
| PD | pupillary diameter | 3 | 0 |
|
|
| PD | phosphorus depletion | 3 | -1 |
|
|
| PD | protein degradation | 3 | -1 |
|
|
| PD | Pharmacokinetic (PK)/pharmacodynamic | 2 | 26 |
|
|
| PD | provocation dose | 2 | 13 |
|
|
| PD | peritoneal | 2 | 13 |
|
|
| PD | Prudent low-fat higher fibre diet | 2 | 10 |
|
|
| PD | pyloric diameter | 2 | 9 |
|
|
| PD | peroxides | 2 | 9 |
|
|
| PD | protein deprivation | 2 | 7 |
|
|
| PD | Parkinson's diseased | 2 | 7 |
|
|
| PD | Pneumatic dilatation | 2 | 6 |
|
|
| PD | phosphodiesterase | 2 | 6 |
|
|
| PD | polydextrose | 2 | 6 |
|
|
| PD | perfusion defect | 2 | 6 |
|
|
| PD | pyloric dilatation | 2 | 5 |
|
|
| PD | pyridinoline | 2 | 5 |
|
|
| PD | phosphate depletion | 2 | 5 |
|
|
| PD | patient's delay | 2 | 5 |
|
|
| PD | panic disorders | 2 | 5 |
|
|
| PD | Poisson distribution | 2 | 5 |
|
|
| PD | Pierce's disease | 2 | 4 |
|
|
| PD | protopanaxadiol | 2 | 4 |
|
|
| PD | putidaredoxin | 2 | 4 |
|
|
| PD | persistent diarrhea | 2 | 4 |
|
|
| PD | plasma desorption | 2 | 3 |
|
|
| PD | platelet deposition | 2 | 3 |
|
|
| PD | paroxysmal discharges | 2 | 3 |
|
|
| PD | prism diopter | 2 | 3 |
|
|
| PD | 13-dibutyrate | 2 | 2 |
|
|
| PD | Père David's | 2 | 2 |
|
|
| PD | perineal descent | 2 | 1 |
|
|
| PD | perinatal death | 2 | 1 |
|
|
| PD | phosphodiester | 2 | 1 |
|
|
| PD | 252Cf-plasma desorption | 2 | 1 |
|
|
| PD | population pharmacokinetics (PK) and pharmacodynamics | 2 | 1 |
|
|
| PD | purine derivatives | 2 | 0 |
|
|
| PD | peritoneal dissemination | 2 | -1 |
|
|
| PD | protein synthesis (PS) and degradation | 2 | -1 |
|
|
| PD | Photodynamic therapy (PDT) and photodiagnosis | 2 | -1 |
|
|
| PD | phase difference | 1 | 19 |
|
|
| PD | Potato Dextrose medium | 1 | 15 |
|
|
| PD | prolonged diestrus | 1 | 15 |
|
|
| PD | pairing day | 1 | 14 |
|
|
| PD | potato-dextrose | 1 | 13 |
|
|
| PD | PD98059 | 1 | 13 |
|
|
| PD | primary | 1 | 12 |
|
|
| PD | Parkinson' disease | 1 | 12 |
|
|
| PD | parallel with cell membrane potential | 1 | 12 |
|
|
| PD | postnatally | 1 | 12 |
|
|
| PD | platelet-derived | 1 | 11 |
|
|
| PD | presynaptic dopaminergic degeneration in Parkinson's disease | 1 | 11 |
|
|
| PD | PD 142893 | 1 | 11 |
|
|
| PD | diastolic | 1 | 10 |
|
|
| PD | protondensity | 1 | 10 |
|
|
| PD | physiological derangement | 1 | 10 |
|
|
| PD | prolonged depolarization | 1 | 10 |
|
|
| PD | posterior digastric | 1 | 9 |
|
|
| PD | plasmodesmata | 1 | 9 |
|
|
| PD | plastid-dividing | 1 | 9 |
|
|
| PD | psychiatric disorder alone | 1 | 9 |
|
|
| PD | pentadeca | 1 | 9 |
|
|
| PD | plasma derived | 1 | 9 |
|
|
| PD | plasma-derived | 1 | 9 |
|
|
| PD | protein-depleted diet | 1 | 9 |
|
|
| PD | Plan Diagnosis | 1 | 9 |
|
|
| PD | proliferative disease | 1 | 8 |
|
|
| PD | phase-derivative | 1 | 8 |
|
|
| PD | physical development | 1 | 8 |
|
|
| PD | patients undergoing partial pancreaticoduodenectomy | 1 | 8 |
|
|
| PD | proximal delivery | 1 | 8 |
|
|
| PD | posterior descending | 1 | 8 |
|
|
| PD | previously diagnosed patients | 1 | 8 |
|
|
| PD | promoter | 1 | 8 |
|
|
| PD | percentage dissatisfaction | 1 | 8 |
|
|
| PD | patients psychodramatherapy | 1 | 8 |
|
|
| PD | permanent dentition | 1 | 8 |
|
|
| PD | prolonged vaginal diestrus | 1 | 8 |
|
|
| PD | pneumology specialists | 1 | 8 |
|
|
| PD | potential-difference | 1 | 8 |
|
|
| PD | potential difference of gastric mucosa | 1 | 8 |
|
|
| PD | adults--panic disorder | 1 | 8 |
|
|
| PD | primary function (NP) versus dysfunction | 1 | 8 |
|
|
| PD | distal | 1 | 8 |
|
|
| PD | psychotic disorder | 1 | 8 |
|
|
| PD | prednisolone | 1 | 8 |
|
|
| PD | paradox | 1 | 8 |
|
|
| PD | periphery in parkinsonian patients | 1 | 8 |
|
|
| PD | pullorum disease | 1 | 8 |
|
|
| PD | paranoid disorder | 1 | 7 |
|
|
| PD | progressive decrease in electrical potential difference | 1 | 7 |
|
|
| PD | pseudoarylsulfatase A deficiency | 1 | 7 |
|
|
| PD | peak demand | 1 | 7 |
|
|
| PD | Polygrapher's Dilemma | 1 | 7 |
|
|
| PD | plateletpheresis donors | 1 | 7 |
|
|
| PD | prolonged diestrous | 1 | 7 |
|
|
| PD | plant density | 1 | 7 |
|
|
| PD | Power Doppler sonography | 1 | 7 |
|
|
| PD | pharyngeal dystrophy | 1 | 7 |
|
|
| PD | potential DNA damage | 1 | 7 |
|
|
| PD | proximal-distal | 1 | 7 |
|
|
| PD | percutaneous discectomy | 1 | 7 |
|
|
| PD | potential difference between CSF and blood | 1 | 7 |
|
|
| PD | per 1000 patient-days | 1 | 7 |
|
|
| PD | patients with | 1 | 7 |
|
|
| PD | patients idiopathic parkinsonism | 1 | 7 |
|
|
| PD | power used to overcome drag | 1 | 6 |
|
|
| PD | point-dipole | 1 | 6 |
|
|
| PD | parkinsonian | 1 | 6 |
|
|
| PD | partially derepressed | 1 | 6 |
|
|
| PD | predegenerated (10 days after transection) | 1 | 6 |
|
|
| PD | partially dependent | 1 | 6 |
|
|
| PD | patients diagnosed with panic disorder | 1 | 6 |
|
|
| PD | penetration depth | 1 | 6 |
|
|
| PD | partial duodenopancreatectomy | 1 | 6 |
|
|
| PD | Postpartum Day | 1 | 6 |
|
|
| PD | previously diagnosed | 1 | 6 |
|
|
| PD | paroxysmal dystonia | 1 | 6 |
|
|
| PD | portion of the duodenum | 1 | 6 |
|
|
| PD | polymeric diet | 1 | 6 |
|
|
| PD | patterns during movements in Parkinson's disease | 1 | 6 |
|
|
| PD | pancreaticoduodenectomies | 1 | 6 |
|
|
| PD | period of dilatation | 1 | 6 |
|
|
| PD | period doubling | 1 | 6 |
|
|
| PD | protein diet | 1 | 6 |
|
|
| PD | Parkinsonian rat | 1 | 6 |
|
|
| PD | permeability coefficient of albumin | 1 | 6 |
|
|
| PD | protein deposition | 1 | 6 |
|
|
| PD | peritoneum during peritoneal dialysis | 1 | 6 |
|
|
| PD | pupillary dilation | 1 | 6 |
|
|
| PD | psychiatric disorders | 1 | 5 |
|
|
| PD | postoperative outcome following pancreaticoduodenectomy | 1 | 5 |
|
|
| PD | pharmacokinetic (PK) and systemic pharmacodynamic | 1 | 5 |
|
|
| PD | Pubic diastasis | 1 | 5 |
|
|
| PD | personality disordered | 1 | 5 |
|
|
| PD | potential derived | 1 | 5 |
|
|
| PD | persistent diestrous | 1 | 5 |
|
|
| PD | partially dependent older adults | 1 | 5 |
|
|
| PD | peroxisome-deficient | 1 | 5 |
|
|
| PD | permeability after duodenopancreatectomy | 1 | 5 |
|
|
| PD | peritonitis during peritoneal dialysis | 1 | 5 |
|
|
| PD | pseudo arylsulfatase-A deficiency | 1 | 5 |
|
|
| PD | protein - energy deprivation | 1 | 5 |
|
|
| PD | patients with Parkinson's-disease | 1 | 5 |
|
|
| PD | panic disorder with (PDA) or without | 1 | 5 |
|
|
| PD | Parkinson's disease dementia | 1 | 5 |
|
|
| PD | protein deprived diet | 1 | 5 |
|
|
| PD | probability | 1 | 5 |
|
|
| PD | panic attacks | 1 | 5 |
|
|
| PD | private dispensaries | 1 | 5 |
|
|
| PD | pancreatic disease | 1 | 5 |
|
|
| PD | part of the distal tibia | 1 | 5 |
|
|
| PD | phosphorous deprivation | 1 | 5 |
|
|
| PD | (CM)-prephenate dehydratase | 1 | 5 |
|
|
| PD | palmarodorsal | 1 | 4 |
|
|
| PD | prostatic disorders | 1 | 4 |
|
|
| PD | power Doppler ultrasound | 1 | 4 |
|
|
| PD | 2-propanediol | 1 | 4 |
|
|
| PD | pressure-diameter | 1 | 4 |
|
|
| PD | protein-deficient mice | 1 | 4 |
|
|
| PD | modalities--peritoneal dialysis | 1 | 4 |
|
|
| PD | partial donor | 1 | 4 |
|
|
| PD | Parkinsonism | 1 | 4 |
|
|
| PD | Monselice-Montagnana | 1 | 4 |
|
|
| PD | pregnancy dependence | 1 | 4 |
|
|
| PD | powdered | 1 | 4 |
|
|
| PD | patients with parkinsonism-dementia | 1 | 4 |
|
|
| PD | posterior deltoid | 1 | 4 |
|
|
| PD | posterior cruciate ligament in proton-density | 1 | 4 |
|
|
| PD | percent deviation | 1 | 4 |
|
|
| PD | pleural dissemination | 1 | 4 |
|
|
| PD | phonological dyslexics | 1 | 4 |
|
|
| PD | pneumatic disk | 1 | 4 |
|
|
| PD | photoinhibition in the autotrophic mutant DeltaR225-F239 | 1 | 4 |
|
|
| PD | polyol dehydrogenase | 1 | 4 |
|
|
| PD | plasma deproteinates | 1 | 4 |
|
|
| PD | postsynaptic density | 1 | 4 |
|
|
| PD | peritoneum | 1 | 4 |
|
|
| PD | permeability during peritoneal dialysis | 1 | 4 |
|
|
| PD | proposed mechanism of the DNA-drug | 1 | 4 |
|
|
| PD | passive diameters | 1 | 4 |
|
|
| PD | potential difference across the plasma membrane | 1 | 4 |
|
|
| PD | anti-Parkinson's disease | 1 | 3 |
|
|
| PD | poorly differentiated | 1 | 3 |
|
|
| PD | Patients with disease progression | 1 | 3 |
|
|
| PD | probability of erythroid differentiation | 1 | 3 |
|
|
| PD | probability of discrimination | 1 | 3 |
|
|
| PD | partially detubularized | 1 | 3 |
|
|
| PD | professional development | 1 | 3 |
|
|
| PD | progestin-dependent | 1 | 3 |
|
|
| PD | progressing disease | 1 | 3 |
|
|
| PD | proton density-weighted | 1 | 3 |
|
|
| PD | pyruvate dehydrogenase multienzyme | 1 | 3 |
|
|
| PD | pronephric (Wolffian) duct | 1 | 3 |
|
|
| PD | permeabilities | 1 | 3 |
|
|
| PD | Parkinson's diseas | 1 | 3 |
|
|
| PD | probability of death | 1 | 3 |
|
|
| PD | population doubling number | 1 | 3 |
|
|
| PD | 2-diol | 1 | 3 |
|
|
| PD | piribedil | 1 | 3 |
|
|
| PD | Protein deficit | 1 | 3 |
|
|
| PD | Pressure differentials | 1 | 3 |
|
|
| PD | pathway damaged in Parkinson's disease | 1 | 3 |
|
|
| PD | Plummer's disease | 1 | 3 |
|
|
| PD | pulsed multigated Doppler | 1 | 3 |
|
|
| PD | periodontal diseases | 1 | 3 |
|
|
| PD | Pierce's disease of grape | 1 | 3 |
|
|
| PD | pathophysiologic and pharmacodynamic nonlinear models | 1 | 3 |
|
|
| PD | pockets | 1 | 3 |
|
|
| PD | psychological debriefing | 1 | 3 |
|
|
| PD | perineal dermatitis | 1 | 3 |
|
|
| PD | phenylalanine deaminase | 1 | 3 |
|
|
| PD | pediatric dentist | 1 | 3 |
|
|
| PD | parkinsonism-dementia complex | 1 | 3 |
|
|
| PD | platelet donor | 1 | 3 |
|
|
| PD | phenylbutazone (PhB) and prednisolone | 1 | 2 |
|
|
| PD | pseudodiscrimination group | 1 | 2 |
|
|
| PD | plasma display | 1 | 2 |
|
|
| PD | pneumatic dilation | 1 | 2 |
|
|
| PD | photon deficient areas | 1 | 2 |
|
|
| PD | psychotic depression | 1 | 2 |
|
|
| PD | prudent Western diet | 1 | 2 |
|
|
| PD | pg m-3 | 1 | 2 |
|
|
| PD | peritoneal dialysis-treated | 1 | 2 |
|
|
| PD | pyloric dilators | 1 | 2 |
|
|
| PD | patients dialysed by peritoneal dialysis | 1 | 2 |
|
|
| PD | Poulshock and Deimling | 1 | 2 |
|
|
| PD | partially defined | 1 | 2 |
|
|
| PD | probing depth reduction | 1 | 2 |
|
|
| PD | Parkinsons's disease | 1 | 2 |
|
|
| PD | prevent anastomotic leakage following pancreatoduodenectomy | 1 | 2 |
|
|
| PD | point | 1 | 2 |
|
|
| PD | positive distortion | 1 | 2 |
|
|
| PD | post-natal day | 1 | 1 |
|
|
| PD | pulsed Doppler system | 1 | 1 |
|
|
| PD | periodical disease | 1 | 1 |
|
|
| PD | Paget disease | 1 | 1 |
|
|
| PD | patients had to undergo repeat operation | 1 | 1 |
|
|
| PD | postdocking | 1 | 1 |
|
|
| PD | Peripheral doses | 1 | 1 |
|
|
| PD | peritoneal damage after long-term peritoneal dialysis | 1 | 1 |
|
|
| PD | protein diet (8% protein) ad libitum | 1 | 1 |
|
|
| PD | potential organ donors | 1 | 1 |
|
|
| PD | papilla diameters | 1 | 1 |
|
|
| PD | pelletized | 1 | 1 |
|
|
| PD | primary diagnosis of Parkinson's disease | 1 | 1 |
|
|
| PD | passive diameter | 1 | 1 |
|
|
| PD | placebo + diet | 1 | 1 |
|
|
| PD | pyridaphenthion | 1 | 1 |
|
|
| PD | palmar digital | 1 | 1 |
|
|
| PD | pyridine | 1 | 0 |
|
|
| PD | potato dextrose | 1 | 0 |
|
|
| PD | peritoneal metastases | 1 | 0 |
|
|
| PD | peri-ductal extension | 1 | 0 |
|
|
| PD | proximodistal | 1 | 0 |
|
|
| PD | pancreaticoenteric continuity after pancreatoduodenectomy | 1 | 0 |
|
|
| PD | Pick disease | 1 | 0 |
|
|
| PD | progression of disease | 1 | 0 |
|
|
| PD | pooled database | 1 | 0 |
|
|
| PD | polysomnograms from 10 | 1 | 0 |
|
|
| PD | protein density | 1 | 0 |
|
|
| PD | proportional-derivative closed-loop | 1 | 0 |
|
|
| PD | prodrug of prednisolone | 1 | -1 |
|
|
| PD | predenervated | 1 | -1 |
|
|
| PD | psychiatric distress | 1 | -1 |
|
|
| PD | process dissociation | 1 | -1 |
|
|
| PD | positive inotropic effect of plasma-dissolved | 1 | -1 |
|
|
| PD | primary cultures of progestin-dependent | 1 | -1 |
|
|
| PD | phi X174 | 1 | -1 |
|
|
| PD | parkinsonism dementia | 1 | -1 |
|
|
| PD | polyclonal desmin | 1 | -2 |
|
|
| PD | phase detector | 1 | -2 |
|
|
| PD | prepulse duration | 1 | -2 |
|
|
| PD | Prednisolone pharmacokinetics (PK) and pharmacodynamics | 1 | -2 |
|
|
| PD | pseudo arylsulfatase A deficiency trait | 1 | -2 |
|
|
| PD | partial deficiency | 1 | -2 |
|
|
| PD | peritonal dialysis | 1 | -2 |
|
Run A Search
Search either direction
By Acronym
By Full Name